NCT02746445View on ClinicalTrials.gov

A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Autistic Disorder
Interventions
OTHER

No intervention

No intervention. This is a longitudinal study looking at subjects who received MeRT treatment.

Trial Locations (1)

92660

Brain Treatment Center, Newport Beach

All Listed Sponsors
lead

Wave Neuroscience

INDUSTRY

NCT02746445 - A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT | Biotech Hunter | Biotech Hunter